Category: Regulations
-
FDA Clears First Sensor-Pill and App System
The Food and Drug Administration approved for the first time in the U.S. a system that combines pills with built-in sensors and a mobile app to track adherence.
-
Infographic: Largest Hacker Breaches and Regulation Tech
Among the most visible and challenging regulatory issues for companies is security breaches, where companies’ systems are attacked with valuable data stolen.
-
FDA Sets Genetic Health Test Review Process
The U.S. Food and Drug Administration is proposing new review requirements for genetic tests of health risks that providers market directly to consumers.
-
Infographic – Costs of Climate Change Soar
Our friends at Statista provide a look at the financial impact of climate change since 1990, just from extreme weather events.
-
Report – 126 Alzheimer’s Drugs in Clinical Trials
A foundation supporting research on new drugs to treat Alzheimer’s disease says clinical trials now underway are testing 126 potential therapies for the disorder.
-
Cancer Drug Price Rises Shown Unrelated to Competition
An analysis of cancer drugs shows their prices steadily increased over 16 years despite competition from newer drugs on the market.
-
Here’s What a Real Opioid Emergency Looks Like
Let’s be clear — the limited steps ordered by the president to reduce the numbers of people addicted to opioids don’t look anything like a response to an emergency.
-
Blood-Thinning Drugs Linked with Lower Dementia Risk
People with irregular heart rhythms given anti-coagulation drugs to reduce their risk of stroke were also less likely to develop dementia than their counterparts not receiving blood-thinners.
-
Biosimilars Seen Saving U.S. $54 Billion
An analysis of health care costs shows increasing the use of substitute biologic treatments known as biosimilars could save the United States some $54 billion over 10 years.
-
Live Skin Bacteria Shown to Control Acne
First results of a clinical trial show a spray-on formulation of live bacteria reduced the amount and severity of acne in people with mild to moderate cases of the condition.